R Cascão, JE Fonseca, LF Moita - Frontiers in medicine, 2017 - frontiersin.org
The identification of new bioactive compounds derived from medicinal plants with significant therapeutic properties has attracted considerable interest in recent years. Such is the case of …
X Liu, P Zhao, X Wang, L Wang, Y Zhu, Y Song… - Journal of Experimental …, 2019 - Springer
Background Celastrol, a triterpene compound derived from the traditional Chinese medicine Tripterygium wilfordii, has been reported to possess potential antitumor activity towards …
C Wang, S Dai, X Zhao, Y Zhang, L Gong, K Fu… - Biomedicine & …, 2023 - Elsevier
Celastrol is a pentacyclic triterpenoid extracted from the traditional Chinese medicine Tripterygium wilfordii Hook F., which has multiple pharmacological activities. In particular …
Y Du, M Han, K Cao, Q Li, J Pang, L Dou, S Liu, Z Shi… - ACS …, 2021 - ACS Publications
Reprograming the N 6-methyladenosine (m6A) landscape is a promising therapeutic strategy against recalcitrant leukemia. In this study, we synthesized gold nanorods (GNRs) …
RJ Packer, S Pfister, E Bouffet, R Avery… - Neuro …, 2017 - academic.oup.com
For the past decade, it has been recognized that pediatric low-grade gliomas (LGGs) and glial-neuronal tumors carry distinct molecular alterations with resultant aberrant intracellular …
A Chen, AN Koehler - Trends in molecular medicine, 2020 - cell.com
Transcription factors have roles at focal points in signaling pathways, controlling many normal cellular processes, such as cell growth and proliferation, metabolism, apoptosis …
V Walf-Vorderwülbecke, K Pearce, T Brooks, M Hubank… - Leukemia, 2018 - nature.com
Despite advances in our understanding of the molecular basis for particular subtypes of acute myeloid leukemia (AML), effective therapy remains a challenge for many individuals …
K Ramaswamy, L Forbes, G Minuesa, T Gindin… - Nature …, 2018 - nature.com
Aberrant gene expression is a hallmark of acute leukemias. MYB-driven transcriptional coactivation with CREB-binding protein (CBP)/P300 is required for acute lymphoblastic and …
Targeting of general coactivators is an emerging strategy to interfere with oncogenic transcription factors (TFs). However, coactivator perturbations often lead to pleiotropic effects …